Obedience and motivation as mechanisms for adherence to medication: a study in obese type 2 diabetic patients

被引:16
|
作者
Reach, Gerard [1 ,2 ]
机构
[1] Hop Avicenne, APHP, Serv Endocrinol, Dept Endocrinol Diabet & Metab Dis, F-93000 Bobigny, France
[2] Univ Paris 13, CRNH IdF, EA 3412, Bobigny, France
来源
关键词
adherence; compliance; motivation; obedience; reactance; patience; seatbelt; medication; GLYCEMIC CONTROL; CARE; HOSPITALIZATION; NONCOMPLIANCE; OSTEOPOROSIS; PREVALENCE; BEHAVIORS; MORTALITY; REACTANCE; MELLITUS;
D O I
10.2147/PPA.S24518
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To clarify the mechanisms of adherence. Methods: A cross-sectional, multicenter French study using a self-questionnaire administered by 116 general practitioners to 782 obese type 2 diabetic patients. Results: The analysis of 670 completed questionnaires revealed a strong association between the adherence to medication and the behavior of fastening the seatbelt when seated in the rear of a car. Multivariate analysis indicated that this behavior was an independent determinant of adherence to medication (odds ratio [OR] 2.3, 95% confidence interval [CI] 1.4-3.6, P < 0.001) with the same OR as the motivation to adhere to medical prescriptions (OR 2.2, 95% CI 1.3-3.6, P = 0.003) in a model with good accuracy (area under the receiver operating characteristic curve 0.774). A multiple correspondence analysis suggested that adherence to medication and seatbelt behavior are "homologous" behaviors, with homology between phenomena defined by the fact that they share a common etiology. Conclusion: Adherence may have two dimensions: passive (obedience, the main determinant of seatbelt behavior) and active (motivation). This conclusion has theoretical and practical implications. Firstly, empowerment through patient education can be defined as a process that replaces the passive mechanism of adherence in patients' minds with an active, conscious choice. Secondly, recognizing these two dimensions may help to establish a tailored patient-physician relationship to prevent nonadherence.
引用
收藏
页码:523 / 531
页数:9
相关论文
共 50 条
  • [1] Monitoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas
    Winkler, A
    Teuscber, AU
    Mueller, B
    Diem, P
    [J]. SWISS MEDICAL WEEKLY, 2002, 132 (27-28) : 379 - 385
  • [2] Adherence to oral hypoglycemic medication in type 2 diabetic patients in Isfahan, Iran: prevalence and barriers to adherence
    Farsaei, S.
    Sabzghabaee, A. M.
    Zargarzadeh, A. H.
    Amini, M.
    [J]. PHARMACY WORLD & SCIENCE, 2010, 32 (05): : 677 - 677
  • [3] Assessment of medication adherence among type 2 diabetic patients in Quetta city, Pakistan
    Iqbal, Qaiser
    Bashir, Sajid
    Iqbal, Javeid
    Iftikhar, Shehla
    Godman, Brian
    [J]. POSTGRADUATE MEDICINE, 2017, 129 (06) : 637 - 643
  • [4] Medication Adherence in Patients With Type 2 Diabetes
    Hennessey, Erin K.
    Peters, Golden L.
    [J]. US PHARMACIST, 2019, 44 (06) : 40 - 46
  • [5] COMPARATIVE STUDY OF SERUM LIPID PROFILE IN OBESE TYPE 2 DIABETIC PATIENTS WITH OBESE NON DIABETIC PATIENTS
    Darshna, Jain
    Shaikh, M. K. S.
    Jha, R. K.
    Shilpa, Mittal
    Deepasha, Shahi
    [J]. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2014, 3 (65): : 14129 - 14136
  • [6] Impact of family support improvement behaviors on anti diabetic medication adherence and cognition in type 2 diabetic patients
    Tabasi H.K.
    Madarshahian F.
    Nikoo M.K.
    Hassanabadi M.
    Mahmoudirad G.
    [J]. Journal of Diabetes & Metabolic Disorders, 13 (1):
  • [7] Pharmacist counseling and mobile health technologies: impact on medication adherence for type 2 diabetic patients
    Lallemand, A.
    Delhaye, N.
    Verrue, C.
    Santi, A.
    Tomas, M.
    Attipoe, A.
    Willaert, M.
    Philippe, G.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (01)
  • [8] The determinants of anti-diabetic medication adherence based on the experiences of patients with type 2 diabetes
    Dehdari, Laleh
    Dehdari, Tahereh
    [J]. ARCHIVES OF PUBLIC HEALTH, 2019, 77 (1)
  • [9] PHYSICIANS UNDERESTIMATE MEDICATION ADHERENCE OF OBESE PATIENTS
    Huizinga, M. M.
    Beach, M. C.
    Bleich, S. N.
    Clark, J. M.
    Cooper, L. A.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 140 - 141
  • [10] PATIENT-RELATED BARRIERS TO MEDICATION ADHERENCE IN TYPE 2 DIABETIC PATIENTS: A SYSTEMATIC REVIEW
    Salkar, M.
    Sah, J.
    Pinto, S.
    Vaidya, V.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A18 - A18